When was Medbanks Network Technology founded?
Medbanks Network Technology was founded in 2014.
Where is Medbanks Network Technology's headquarters?
Medbanks Network Technology's headquarters is located at Building 17, Xinqiwang Office Building, No.1 Dongdadi Street, Dongcheng District, Beijing.
What is Medbanks Network Technology's latest funding round?
Medbanks Network Technology's latest funding round is Series E.
How much did Medbanks Network Technology raise?
Medbanks Network Technology raised a total of $546.47M.
Who are the investors of Medbanks Network Technology?
Investors of Medbanks Network Technology include Tencent Holdings, Wu Capital, Jeneration Capital, 5Y Capital, Forebright Capital Management and 8 more.
Who are Medbanks Network Technology's competitors?
Competitors of Medbanks Network Technology include Evidation.
You May Also Like
Medable is a decentralized clinical trial software company. The company's Software-as-a-Service (SaaS) cloud platform aims to provide a path to secure, HIPAA-compliant healthcare applications for researchers, startups, pharma, payers, and academia. This platform allows for supporting patient engagement clinical applications, storing personal health information, and complying with HIPAA and other regulations. Medable aims to enable patient-generated data to drive clinical research, healthcare delivery, and personalized and predictive medicine.
Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.
Neurocast is a 24/7 digital biomarker for measuring patients' performance. Neurokeys combines keystroke dynamics data with sensor data, health data from a smartphone and various open datasets. This enables the company to analyze step and staircase counters to provide insights in physical fatigue.
TriNetX is the global health research network that optimizes clinical research and enables discoveries through the creation of real-world evidence. TriNetX combines real-time access to longitudinal clinical data with analytics to answer complex research questions.
MediMergent is a data collection and analytics company focused on Real-World Data (RWD) and Real-World Evidence (RWE) related to patients’ health status. MediMergent has built and deployed a digital platform that collects RWD from customized patient surveys, medical records, health insurance claims and billing data, pharmacy prescriptions and refill data, and, where appropriate, information from wearable medical devices and apps. MediMergent combines this data, acquired directly from the patients, that relate to first-hand accounts of their perceived risk versus benefit relationship for select medications, to generate a unique set of data or evidence (RWE) related to improve outcomes and reduce costs of healthcare. Using proprietary algorithms, MediMergent produces data that can be used by the entire healthcare ecosystem including prescribers, pharmacists, health insurers, pharmaceutical companies, corporations, regulators and importantly, patients.
Aetion delivers real-world evidence for life sciences companies, payers, at-risk providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce rapid and scientifically validated answers on treatments, costs, and outcomes. Aetion informs health care's most critical decisions - what works best, for whom, and when - to guide treatment development, commercialization, and payment values into health care's modern era.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.